logo
New hope for ash trees ‘evolving resistance to deadly disease'

New hope for ash trees ‘evolving resistance to deadly disease'

Telegraph5 hours ago

Ash trees are finally mounting a fightback against ash dieback disease, a study has found.
The fungal infection has devastated UK ash populations since it arrived on British shores more than a decade ago, with experts warning it could wipe out the species.
A study by the Royal Botanic Gardens, Kew, and Queen Mary, University of London tracked how the disease was affecting an ancient woodland in Surrey.
Ash dieback has ravaged the Marden Park wood since 2012 with the majority of trees being infected. Dieback causes blackened leaves, stunted growth and shrivelled roots.
But a comparison of the health and genes of trees that matured before 2012 against recent saplings discovered evolution in action, which is making young trees more resilient.
The modern plants had different variations of almost 8,000 genes, accrued by natural selection, which made them more robust, scientists found.
A population's range of genes emerges naturally and randomly, but only those that are advantageous survive long enough to reproduce. Over several generations, genes that make an organism vulnerable die out, and advantageous genes and traits persist in the population.
The new study found that this process weeded out almost a third of the newest ash trees, leaving the 69 per cent that were genetically better able to withstand ash dieback.
The end result is that current juvenile ash trees in this woodland are better able to combat and less likely to die from the disease.
Glimmer of hope against extinction
This offers a glimmer of hope that the British native ash tree, known as Fraxinus excelsior, will not go extinct as some experts had feared.
Ash dieback is caused by the fungus Hymenoscyphus fraxineus and arrived in Britain from Asia in 2012, prompting an emergency Cobra meeting.
British ash trees are uniquely vulnerable to the disease, which does not harm other ash species, including those found on mainland Europe.
The disease has since wreaked havoc across the British countryside, leaving behind skeletal remains of dying ash trees.
Previous predictions estimated that up to 85 per cent of ash trees in the UK would succumb to the disease, with none displaying complete immunity.
They say it also demonstrates this process works even when a certain trait, such as disease protection, is created by lots of different genes, and not just a single chunk of DNA.
Dr Carey Metheringham, whose PhD research included the study, said: 'Thanks to natural selection, future generations of ash should have a better chance of withstanding infection.'
But she also warned that while natural selection is showing signs of an ash fightback, it may not be enough on its own to overcome the dieback threat.
Evolution may not be enough
'Natural selection alone may not be enough to produce fully resistant trees,' Ms Metheringham added.
'The existing genetic variation in the ash population may be too low, and as the trees become scarcer, the rate of selection could slow.
' Human intervention, such as selective breeding and the protection of young trees from deer grazing, may be required to accelerate evolutionary change.'
Additional steps could be needed to prevent ash from facing the same extinction threat as the elm tree, which is being decimated by Dutch elm disease.
The study was largely funded by the Department for Environment, Food and Rural Affairs, which is also leading other work to try and help the ash tree.
The new study is published in the journal Science.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Boots and Specsavers to take over NHS care
Boots and Specsavers to take over NHS care

Telegraph

time2 hours ago

  • Telegraph

Boots and Specsavers to take over NHS care

Companies such as Boots and Specsavers will offer more NHS care under plans to shift services onto the high street. Wes Streeting said a 10-year health plan would set out a much greater role for private companies in carrying out checks normally done in hospital. The Health Secretary also said shifting care out of hospitals into the community would mean more services in shopping areas, close to people's homes, to make them more convenient. Mr Streeting said: 'There's definitely a role for high street players like Boots and Specsavers to help cut NHS waiting lists and to help provide great care and services and advice to patients as part of the wider primary care team.' Under the plans, GPs will take a bigger role leading neighbourhood health services, which could bring a range of services together. This could result in pharmacies offering a wider range of checks and services, and high street opticians carrying out assessments and diagnostics for common eye conditions, he suggested. Mr Streeting said the plans would aim to create 'a real partnership between GPs and other parts of the primary care system' – instead of them scrapping over resources. He said the shift away from hospitals would see more NHS services, including those run directly by the NHS, on the high street. Last year the NHS launched a scheme that means people can consult pharmacists about seven common conditions – including sore throats, earache and urinary tract infections – instead of having to make an appointment with a doctor. Health officials are looking to expand the role of pharmacists further, dealing with a wider range of conditions, relieving pressures on GP surgeries. Hospitals could also take over the running of GP practices, as part of efforts to improve access to care across neighbourhoods. Last week the Health Secretary said he would not shrink from leaning more heavily on the private sector to improve access to NHS care. Wes Streeting said he 'refused to be bound by outdated ideological battles', saying using independent hospitals to provide taxpayer-funded care did not contradict the principles of the health service. Writing for The Telegraph he said he would fight for the future of the NHS, warning of a 'national emergency' facing the country. Mr Streeting made the comments as new figures showed that almost 1.4 million people have had private care on the NHS since Labour won the election. Next week he will launch a 10-year plan for the NHS, which promises three major shifts – from hospital to community, from analogue to digital and from treating sickness to prevention, with private sector involvement expected to play a key role. Elsewhere under the plans, patients will be able to refer themselves for therapy through the NHS app. Instead of having to turn to costly mental health apps, the NHS app 'offers a free service built by trusted clinicians', according to a spokesman. Some 6,700 more mental health workers have been recruited since July 2024. Mr Streeting said: 'Not getting the right support for your mental health isn't just debilitating, it can hit a painful pause button on your life – stopping you working, enjoying time with family and friends, or living day-to-day life. 'Patients have faced the crisis of access to mental health services for far too long, and this Government is determined to change that through our Plan for Change to rebuild the NHS. 'That's why we're putting digital front doors on mental health services for patients up and down the country and harnessing technology to provide 24-hour care. And we're creating more opportunities for support not just through the NHS App but through care in your community too. 'We are already over halfway towards our target of recruiting 8,500 extra mental health workers, and through our upcoming 10 year health plan we will get more people back to health and back to work.'

Interpol seizes erectile dysfunction and anti-anxiety medication
Interpol seizes erectile dysfunction and anti-anxiety medication

Telegraph

time3 hours ago

  • Telegraph

Interpol seizes erectile dysfunction and anti-anxiety medication

Erectile dysfunction and anti-anxiety medication were among the most common illegal pharmaceuticals seized by Interpol in a cluster of raids spanning 90 countries. Investigators retrieved £47 million worth of counterfeit or illegal medication as part of an operation codenamed Pangea XVII. From December 2024 to May, police arrested 769 suspected drug traffickers and dismantled 123 criminal gangs. Psychostimulants, anti-anxiety drugs and medications for Parkinson's disease topped the list as the most seized product type. Erectile dysfunction medicines were the second highest. In Britain, drugs seized included painkillers, antidepressants and sleeping pills. Australia recorded the largest seizures globally, with psychostimulants (drugs used to treat sleepiness) modafinil and armodafinil being the most common. This was followed by anti-smoking nicotine pouches and erectile dysfunction medicines. Ozempic -style weight loss drugs, such as semaglutide, and peptides used for bodybuilding and cosmetic enhancements were also seized in huge quantities. The ease of purchasing these drugs either via social media or from online marketplaces are making them rapidly grow in popularity. A single semaglutide pen may sell for several hundred US dollars on the black market, Interpol said. About 13,000 criminal-linked websites, social media pages, channels and bots used to market and sell illegal or falsified medicines have been shut down Criminal networks now view these drugs as 'lucrative and relatively low-risk opportunities' for selling poor quality or counterfeit products. Law enforcement agencies launched 1,728 investigations and issued 847 search warrants targeting criminal networks. Some 93 per cent of the illicit pharmaceuticals seized lacked regulatory approvals from national health authorities. The remaining 7 per cent were confirmed as either counterfeit, diverted, or misbranded products. Malaysia removed the greatest number of online listings (7,000), followed by Russia, Ireland, Singapore and Iran. The five countries collectively accounted for 96 per cent of all listings taken down. In Burkina Faso, 816,000 tablets including analgesics and anti-inflammatories were discovered hidden in vehicles. Mexican authorities intercepted benzodiazepine drugs including 27,000 clonazepam tablets and 20,000 alprazolam tablets passing through a courier facility in Tijuana. In Portugal, anabolic steroids were discovered in eight prisons across the country, unveiling evidence of a criminal network smuggling illicit substances into correctional facilities. 'Serious risk to public health' David Caunter, director pro tempore of organised and emerging crime at Interpol, said: 'Fake and unapproved medications are a serious risk to public health. They can include dangerous or illegal ingredients potentially resulting in severe illness, or even death 'The rapid growth of online platforms has made it easier for these unsafe drugs to reach people as well as opening new opportunities for criminal networks to exploit. 'Working together through Operation Pangea, countries are taking action to protect people's health and keep healthcare systems safe.'

Human genetic code to be built from scratch
Human genetic code to be built from scratch

Telegraph

time3 hours ago

  • Telegraph

Human genetic code to be built from scratch

The human genetic code will be built from scratch by British scientists in a controversial new research project. The £10 million scheme to synthesise DNA is being funded by the Wellcome Trust and involves scientists from universities including Oxford, Cambridge and Imperial College. Since the human genome was decoded at the start of the century, researchers have questioned whether it might be possible to use the blueprint to create genes and chromosomes artificially. In the five year project, the team hopes to create a fully synthetic human chromosome - making up about 2 per cent of human DNA - as a proof of concept. Michael Dunn, director of discovery research at Wellcome, said: ' Our DNA determines who we are and how our bodies work. 'Through creating the necessary tools and methods to synthesise a human genome we will answer questions about our health and disease that we cannot even anticipate yet, in turn transforming our understanding of life and wellbeing.' Researchers say synthetic genomes could help create new cell-based therapies or engineer plant species with new properties, such as being able to withstand pests and warming climates. Synthetic genomes have already been developed for small organisms such as the sexually transmitted bacterium Mycoplasma genitalium and But the human genome is much more complicated. However, experts said it is crucial to make sure the technology is not abused and that regulations are put in place. 'You can only truly understand something if you can build it from scratch,' said Prof Robin Lovell-Badge, group leader of the Francis Crick Institute in London. 'It is critical when developing new technology to understand not just issues of potential utility, but also those concerned with safety and risk. 'If these were to ever be used in humans, it would be important to design them carefully so that they can't lead to tumours or produce novel infectious particles. 'Indeed, I would urge incorporating an inducible genetic kill switch to eliminate them from any location in the body or at least to make them easy for the immune system to find and destroy.' The Wellcome Trust said it was commissioning a separate project to look into the ethics and public opinion on the research. Dr Pat Thomas, director of the campaign group Beyond GM, told the BBC: 'We like to think that all scientists are there to do good, but the science can be repurposed to do harm and for warfare'.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store